01 1Qilu Pharmaceutical
01 1CARBOPLATIN USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-03-28
Pay. Date : 2023-09-27
DMF Number : 24201
Submission : 2010-09-25
Status : Active
Type : II
20
Qilu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CARBOPLATIN USP, with a corresponding US DMF Number 24201.
Remarkably, this DMF maintains an Active status since its submission on September 25, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 28, 2024, and payment made on September 27, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
